Home 新闻中心新闻

新闻

帮您了解冠科生物的最新资讯.

Crown Bioscience Announces the Establishment of Unique EGFR-mutated Non-Small Cell Lung Cancer Models

May 10, 2016

Crown Bioscience Launches MuScreen Platform for Evaluating In Vivo Efficacy of Immuno-oncology Agents

April 26, 2016

Crown Bioscience to Showcase Scientific Expertise at American Association of Cancer Research

April 12, 2016

Crown Bioscience Strengthens Immuno-oncology Capabilities With HuGEMM™

April 5, 2016

Crown Bioscience Licenses its HuBase™ PDX Management Software

March 29, 2016

Crown Bioscience Acquires PreClinOmics, Expands Cardiovascular and Metabolic Disease Portfolio

March 8, 2016

Crown Bioscience to Commercialize University of York’s Prostate Cancer Models for Drug Development

February 11, 2016

Crown Bioscience to Hold Symposium on Precision Medicine and Translating Oncology Drug Discovery into Success in the Clinic

January 28, 2016

Crown Bioscience Names Global Scientific Director for Translational Oncology

January 13, 2016

Crown Bioscience Announces Establishment of NASH Monitoring With its Translational Models

December 16, 2015

© 2025 Crown Bioscience.

中美冠科生物技术(太仓)有限公司苏ICP备10097610号